HOME >> BIOLOGY >> NEWS
Mutation may help cause acute myeloid leukemia

St. Louis, Aug. 1, 2003 -- Researchers at Washington University School of Medicine in St. Louis have found that a chromosome defect often seen in human acute myeloid leukemia (AML) can cause the same disease in mice when combined with a genetic defect in a molecule known as a tyrosine kinase receptor. The study is published online and in the Aug. 5 issue of the Proceedings of the National Academy of Sciences.

"The findings indicate that tyrosine kinases may be an important class of cancer-causing genes in leukemia," says principal investigator Michael H. Tomasson, M.D., assistant professor of genetics and of medicine. "It further suggests that drugs designed to inhibit these molecules might provide effective new treatments for this deadly disease."

AML is a cancer of immature white blood cells. It can lead to severe anemia and immune deficiency and often is fatal. Although AML accounts for less than 3 percent of all cancers, it is the leading cause of cancer death among Americans under age 35. It also strikes older people, in whom it can be difficult to treat.

About 12 percent of AML patients have a chromosomal abnormality that fuses a piece of chromosome 21 to chromosome 8. The genetic mutation leads to production of an abnormal protein known as aml1-eto. But this change alone isn't enough to cause AML in humans or animals.

Tomasson and colleagues examined mice transplanted with bone-marrow cells some of which contained both the aml1-eto defect and a defect in a tyrosine kinase receptor gene known as tel-pdgfrb. With these two mutations, the mice developed AML; mice with only the aml1-eto fusion gene did not develop the disease.

"This is the first study to show that an activated tyrosine kinase receptor can cooperate with aml1-eto to produce AML in laboratory animals," says first author Jay L. Grisolano, Ph.D., a post-doctoral fellow in Tomasson's laboratory. "It raises the possibility that a combination of therapies design
'"/>

Contact: Darrell E. Ward
wardd@msnotes.wustl.edu
314-286-0122
Washington University School of Medicine
1-Aug-2003


Page: 1 2

Related biology news :

1. Mutation causes specific arrhythmia and sudden cardiac death
2. Mutation in DKC1 gene can cause rare aging disease and cancer
3. Mutations may yield clues to heartbreaking childhood disease
4. Mutations in the ABCR gene are an overwhelming cause of inherited vision loss
5. Mutations not the only gene defect that leads to cancer
6. Mutation on Y chromosome stops sperm production
7. Mutation in PTEN gene can cause cancer and autoimmune disease
8. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
9. Genetic Mutations Linked To Rare Metabolic Disease
10. Researchers Discover Genetic Mutation For Rare Form Of Dwarfism
11. Discovery Of Mutation May Lead To Help For Male Fertility Problems

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... ... the National Research Council of Canada (NRC) to create the Laboratory of ... technologies and in manufacturing, LIFT will offer a competitive capacity to accelerate ...
(Date:10/4/2019)... NEW YORK (PRWEB) , ... October 03, 2019 , ... ... the genome that cells hand down from one generation to the next. In a ... mutations can modulate the activity of this enzyme, leading to cancers and other diseases. ...
(Date:9/30/2019)... , ... September 30, 2019 , ... ... focused on increasing the capacity of life science organizations to accelerate innovation and ... Francisco, CA on October 4th. , What: Just 30 days to 21 CFR ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... MELBOURNE, Fla. (PRWEB) , ... October 07, 2019 ... ... and development of low level laser therapy technology (“3LT®”), today announces that the ... to market its EVRL low level laser for the temporary relief of chronic ...
(Date:10/3/2019)... ... October 01, 2019 , ... ... and reset itself, announced the midway point of its randomized research trial for ... study is to measure the efficacy of a non-invasive technology which compares tones ...
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the official ... enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, and ... executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in the ...
(Date:10/3/2019)... FAIRFAX, Va. (PRWEB) , ... October 02, 2019 , ... ... the prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science ... up the adoption of technology in NHS by providing support to develop and deploy ...
Breaking Biology Technology:
Cached News: